» Articles » PMID: 27161065

Dynamic Contrast-enhanced and Dynamic Susceptibility Contrast Perfusion MR Imaging for Glioma Grading: Preliminary Comparison of Vessel Compartment and Permeability Parameters Using Hotspot and Histogram Analysis

Overview
Journal Eur J Radiol
Specialty Radiology
Date 2016 May 11
PMID 27161065
Citations 44
Authors
Affiliations
Soon will be listed here.
Abstract

Introduction: Dynamic susceptibility contrast (DSC)-MRI is a perfusion technique with high diagnostic accuracy for glioma grading, despite limitations due to inherent susceptibility effects. Dynamic contrast-enhanced (DCE)-MRI has been proposed as an alternative technique able to overcome the DSC-MRI shortcomings. This pilot study aimed at comparing the diagnostic accuracy of DSC and DCE-MRI for glioma grading by evaluating two estimates of blood volume, the DCE-derived plasma volume (Vp) and the DSC-derived relative cerebral blood volume (rCBV), and a measure of vessel permeability, the DCE-derived volume transfer constant K(trans).

Methods: Twenty-six newly diagnosed glioma patients underwent 3T-MR DCE and DSC imaging. Parametric maps of CBV, Vp and K(trans) were calculated and the region of highest value (hotspot) was measured on each map. Histograms of rCBV, Vp and K(trans) values were calculated for the tumor volume. Statistical differences according to WHO grade were assessed. The diagnostic accuracy for tumor grading of the two techniques was determined by ROC analysis.

Results: rCBV, Vp and K(trans) measures differed significantly between high and low-grade gliomas. Hotspot analysis showed the highest correlation with grading. K(trans) hotspots co-localized with Vp hotspots only in 56% of enhancing gliomas. For differentiating high from low-grade gliomas the AUC was 0.987 for rCBVmax, and 1.000 for Vpmax and K(trans)max. Combination of DCE-derived Vp and K(trans) parameters improved the diagnostic performance of the histogram method.

Conclusion: This initial experience of DCE-derived Vp evaluation shows that this parameter is as accurate as the well-established DSC-derived rCBV for glioma grading. DCE-derived K(trans) is equally useful for grading, providing different informations with respect to Vp.

Citing Articles

Device-assisted strategies for drug delivery across the blood-brain barrier to treat glioblastoma.

Mokarram N, Case A, Hossainy N, Lyon J, MacDonald T, Bellamkonda R Commun Mater. 2025; 6(1):5.

PMID: 39790893 PMC: 11706785. DOI: 10.1038/s43246-024-00721-y.


Imaging Role in Diagnosis, Prognosis, and Treatment Response Prediction Associated with High-grade Glioma.

Heidari M, Shokrani P J Med Signals Sens. 2024; 14:7.

PMID: 38993200 PMC: 11111132. DOI: 10.4103/jmss.jmss_30_22.


Review of tracer kinetic models in evaluation of gliomas using dynamic contrast-enhanced imaging.

Zhou J, Hou Z, Tian C, Zhu Z, Ye M, Chen S Front Oncol. 2024; 14:1380793.

PMID: 38947892 PMC: 11211364. DOI: 10.3389/fonc.2024.1380793.


Diagnostic Utility of Integration of Dynamic Contrast-Enhanced and Dynamic Susceptibility Contrast MR Perfusion Employing Split Bolus Technique in Differentiating High-Grade Glioma.

Malik V, Kesavadas C, Thomas B, N D, K K Indian J Radiol Imaging. 2024; 34(3):382-389.

PMID: 38912247 PMC: 11188723. DOI: 10.1055/s-0043-1777742.


Longitudinal Evaluation of DCE-MRI as an Early Indicator of Progression after Standard Therapy in Glioblastoma.

Arevalo-Perez J, Trang A, Yllera-Contreras E, Yildirim O, Saha A, Young R Cancers (Basel). 2024; 16(10).

PMID: 38791921 PMC: 11119591. DOI: 10.3390/cancers16101839.